Company / Operating Cash Flow per Share
Mirum Pharmaceuticals, Inc. Operating Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$1.15
FY2025
5-year range
-$4.34 / $1.15
FY2021-FY2025
Trend
+422.6%
vs FY2024
Sector context
#52 of 212
Health Care
What the data says
Operating Cash Flow per Share changed +423% YoY in FY2025, a notable deviation from the 7-year average annual change of -24%.
Based on SEC 10-K filings.
1.15 in FY2025. Top quartile in the Health Care sector.
Improved from $-1.92 to $1.15 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 212This company $1.15 Sector average $5.28
▼
-78.1% below sector average
Key checks
Key Insights
- Mirum Pharmaceuticals, Inc.'s operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 422.6% year-over-year.
- Ranks #52 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.15 | +422.6% |
| FY2024 | $0.22 | +111.5% |
| FY2023 | -$1.92 | +55.8% |
| FY2022 | -$4.34 | -45.1% |
| FY2021 | -$2.99 | +15.2% |
| FY2020 | -$3.53 | -2.9% |
| FY2019 | -$3.43 | -726.2% |
| FY2018 | -$0.41 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026